159 related articles for article (PubMed ID: 18725949)
1. HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.
Wang F; Grigorieva EV; Li J; Senchenko VN; Pavlova TV; Anedchenko EA; Kudryavtseva AV; Tsimanis A; Angeloni D; Lerman MI; Kashuba VI; Klein G; Zabarovsky ER
PLoS One; 2008 Aug; 3(8):e3031. PubMed ID: 18725949
[TBL] [Abstract][Full Text] [Related]
2. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
3. The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer.
Jin Z; Zhang G; Liu Y; He Y; Yang C; Du Y; Gao F
J Gastroenterol Hepatol; 2019 Oct; 34(10):1766-1776. PubMed ID: 30972813
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
[TBL] [Abstract][Full Text] [Related]
5. Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells.
Edjekouane L; Benhadjeba S; Jangal M; Fleury H; Gévry N; Carmona E; Tremblay A
Oncotarget; 2016 Nov; 7(47):77276-77290. PubMed ID: 27764788
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.
Senchenko VN; Anedchenko EA; Kondratieva TT; Krasnov GS; Dmitriev AA; Zabarovska VI; Pavlova TV; Kashuba VI; Lerman MI; Zabarovsky ER
BMC Cancer; 2010 Mar; 10():75. PubMed ID: 20193080
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.
Li J; Wang F; Protopopov A; Malyukova A; Kashuba V; Minna JD; Lerman MI; Klein G; Zabarovsky E
Oncogene; 2004 Aug; 23(35):5941-9. PubMed ID: 15208682
[TBL] [Abstract][Full Text] [Related]
8. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.
Bourguignon V; Flamion B
FASEB J; 2016 Jun; 30(6):2108-14. PubMed ID: 26887442
[TBL] [Abstract][Full Text] [Related]
9. Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer.
Nykopp TK; Pasonen-Seppänen S; Tammi MI; Tammi RH; Kosma VM; Anttila M; Sironen R
Gynecol Oncol; 2015 Apr; 137(1):152-9. PubMed ID: 25584766
[TBL] [Abstract][Full Text] [Related]
10. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.
Ji L; Nishizaki M; Gao B; Burbee D; Kondo M; Kamibayashi C; Xu K; Yen N; Atkinson EN; Fang B; Lerman MI; Roth JA; Minna JD
Cancer Res; 2002 May; 62(9):2715-20. PubMed ID: 11980673
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.
Junker N; Latini S; Petersen LN; Kristjansen PE
Oncol Rep; 2003; 10(3):609-16. PubMed ID: 12684632
[TBL] [Abstract][Full Text] [Related]
12. The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus.
Csóka AB; Frost GI; Heng HH; Scherer SW; Mohapatra G; Stern R
Genomics; 1998 Feb; 48(1):63-70. PubMed ID: 9503017
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
14. Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer.
Kumar K; Kanojia D; Bentrem DJ; Hwang RF; Butchar JP; Tridandapani S; Munshi HG
Cells; 2023 May; 12(11):. PubMed ID: 37296612
[TBL] [Abstract][Full Text] [Related]
15. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.
Nykopp TK; Rilla K; Tammi MI; Tammi RH; Sironen R; Hämäläinen K; Kosma VM; Heinonen S; Anttila M
BMC Cancer; 2010 Sep; 10():512. PubMed ID: 20875124
[TBL] [Abstract][Full Text] [Related]
17. Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells.
Hemming R; Martin DC; Slominski E; Nagy JI; Halayko AJ; Pind S; Triggs-Raine B
Glycobiology; 2008 Apr; 18(4):280-9. PubMed ID: 18234732
[TBL] [Abstract][Full Text] [Related]
18. Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts.
Puissant E; Boonen M
PLoS One; 2016; 11(10):e0165004. PubMed ID: 27755597
[TBL] [Abstract][Full Text] [Related]
19. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
[TBL] [Abstract][Full Text] [Related]
20. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
